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On day 22 of illness, generalized tonic-clonic convul-
sion developed in a 32-year-old woman with severe acute
respiratory syndrome (SARS). Cerebrospinal fluid tested
positive for SARS coronavirus (SARS-CoV) by reverse
transcriptase–polymerase chain reaction. SARS-CoV may
have caused an infection in the central nervous system in
this patient.
S
evere acute respiratory syndrome (SARS) is an acute
febrile illness predominantly involving the lungs, and a
high proportion of patients die of respiratory failure (1).
However, the novel coronavirus causing SARS appears not
to be confined to the lungs, as suggested by observation of
diarrhea (2), impaired liver function tests, lymphopenia,
and thrombocytopenia (3). We report a case of possible
involvement of the central nervous system by the SARS-
coronavirus (SARS-CoV). 
Case Report
A 32-year-old woman in week 26 of pregnancy, who
was previously in good health, was admitted to the hospi-
tal on March 29, 2003 with myalgia for 1 week and fever,
chills, and rigor for 2 days. She had an unproductive cough
and no sore throat. On admission, her temperature was
38.8°C, with chest radiograph showing patchy consolida-
tions over the right upper lobe and both lower lobes. Total
leukocyte count was 12.3 × 109/L and lymphocyte count
was 1.6 × 109/L. Hemoglobin level, liver and renal func-
tion tests, and serum lactate dehydrogenase were normal.
Ribavirin (500 mg every 8 hours) and hydrocortisone
(100 mg every 8 hours) were administered intravenously.
Clinical and radiologic deterioration progressed, and by
day 7, mechanical ventilation was begun. Onset of acute
renal failure began on day 8, with oliguria and rapidly ele-
vating serum urea and creatinine levels, and a decision was
made to terminate the pregnancy. Lower-segment cesarean
section was performed on the same day, and a baby girl,
appropriate to the gestational age, was born. Mechanical
ventilation continued, but renal function continued to dete-
riorate. She was given piperacillin/tazobactam to cover
possible sepsis. On day 10, the serum creatinine level was
504 µmol/L, and the patient was still oliguric, necessitat-
ing hemodialysis intermittently from day 10 to day 18. The
diuretic phase occurred on day 19, and her renal functions
improved progressively.
On day 22, the patient was still on mechanical ventila-
tion and was sedated with an infusion of 30 mg of midazo-
lam plus 30 mg of morphine in 50 mL 5% dextrose solu-
tion at 6 mL per hour. During the previous 2 days, she had
a low-grade fever. Early that afternoon she had a general-
ized tonic-clonic convulsion with loss of consciousness
and up-rolling eyeballs lasting for 1 minute. She had no
neck rigidity and no residual neurologic deficit. Lumbar
puncture performed later that day showed an opening pres-
sure of 15 cm of water, with free flow of clear cere-
brospinal fluid (CSF). Total CSF protein was 0.38 g/L, and
CSF glucose was 5.1 mmol/L, against blood glucose of
6.6 mmol/L. Microscopy showed an erythrocyte count of
20 per mm
3 and a leukocyte count of <1 per mm
3. Gram
stain, bacterial cultures, and viral cultures were negative.
However, reverse transcriptase–polymerase chain reaction
(RT-PCR) on CSF for the SARS-CoV was positive. Serum
calcium was 1.96 mmol/L against a serum albumin of
27 g/L, serum magnesium was 0.62 mmol/L (normal
range 0.7–1.1 mmol/L), serum sodium was 152 mmol/L
(normal range 135–149 mmol/L), serum potassium was
4.0 mmol/L, and serum creatinine was 311 µmol/L. Both
the electroencephalogram done on day 39 and magnetic
resonance imaging done on day 46 showed no abnormali-
ties. She had no other convulsions.
Renal function and respiratory status continued to
improve. She was extubated on day 27 and made an
uneventful recovery. Immunoglobulin G antibody titer of
the SARS-CoV by immunofluorescence assay was <1:25
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PCR for SARS-CoV was also positive in stool specimens
and peritoneal fluid.
Conclusions
In our patient, the occurrence of generalized convulsion
with a positive RT-PCR for SARS-CoV in the CSF sug-
gests possible infection of the central nervous system by
SARS-CoV. Other possible causes of convulsion were
considered. The slightly high serum sodium that gradually
developed over 3 days was likely related to
piperacillin/tazobactam administration and was unlikely to
be responsible for the convulsion. Cerebral hypoxemia
was unlikely, as the patient was monitored closely in the
intensive care unit, and records did not show sustained
arterial oxygen desaturation. Acute renal failure was also
unlikely as the patient’s renal function was improving, and
one would expect convulsion caused by acute renal failure
to occur during the worsening phase or at the height of the
renal impairment. Acid-base disturbances were absent.
Although serum magnesium was somewhat low
(0.69 mmol/Lafter correction for serum protein concentra-
tion using the formula suggested by Kroll and Elin [4]),
convulsions are usually associated with much lower levels
(5). No hypertension or proteinuria existed to suggest
eclampsia. Also, preeclampsia occurs when the placenta is
present, and termination of pregnancy is the standard treat-
ment for severe preeclampsia (6). Ribavirin has not been
reported to cause convulsion, and it would be very unlike-
ly for such an event to occur 5 days after discontinuation.
The possibility of a false-positive RT-PCR test result
was also considered. To our knowledge, a genuine false-
positive test has not been reported in the literature in any
clinical specimen. Nonetheless, the CSF sample could
have been contaminated with the patient’s own blood,
which contained genetic material of SARS-CoV. However,
finding only 20 erythrocytes per mm3 in the CSF makes
this unlikely.
Human coronavirus (HCoV) is responsible for up to
one third of upper respiratory tract infections (7). It can
enter susceptible cells through the endocytic pathway (8).
Two strains (229E and OC43) have been implicated in
multiple sclerosis (9,10), and both can persistently infect
human oligodendrocytic and neuroglial cell lines (11).
More recently, a combination of RT-PCR and Southern
hybridization on human brain autopsy samples provided
more definitive experimental evidence for the neurotro-
pism and neuroinvasion of HCoV and its possible associa-
tion with multiple sclerosis (12). Preliminary work in
Hong Kong with RT-PCR on SARS autopsy specimens of
brain tissue were positive for SARS-CoV, although elec-
tron microscopy did not show ultrastructural features of
the virus (W.-C. Yu, unpub. data). The findings from our
patient are not compatible with multiple sclerosis, and the
PCR result suggests that the central nervous system (CNS)
is affected by SARS-CoV.
Another lumbar puncture cannot be repeated to test the
CSF by RT-PCR. The presence of SARS-CoV in the CNS
cannot be firmly established. The possibility also remains
that infection of the CNS never occurred, as suggested by
the lack of focal neurologic deficit, normal CSF pressure,
cell count, and biochemistry. The normal electroen-
cephalogram and magnetic resonance imaging might have
missed the pathologic changes, as they were done 17 and
24 days after the event. In the absence of a good alterna-
tive explanation for the convulsion, the diagnosis of infec-
tion of the CNS by SARS-CoV is still possible, despite a
lack of supportive evidence. The hospital has managed a
total of 577 definite SARS patients in this period, and this
is the only patient who had a convulsion. This was the only
single patient who had a lumbar puncture, suggesting that
the involvement of the CNS in SARS is rare.
Besides involvement of the lungs and possibly the
CNS, no good alternative explanation exists for acute renal
failure in this patient. Renal failure could possibly be
caused by SARS-CoV involving the kidneys. Additionally,
our patient had diarrhea from day 3 to day 20, with posi-
tive RT-PCR for SARS-CoV in stool specimens, suggest-
ing involvement of the gastrointestinal tract as well. In
conclusion, our case demonstrates that SARS-CoV can
possibly infect multiple organ systems and that CNS can
potentially be involved.
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